Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Social Harms in Female-INITIATED hiv prevention method RESEARCH: state of the evidence.

Montgomery ET, Roberts ST, Nel A, Malherbe M, Torjesen K, Bunge K, Singh D, Baeten JM, Marrazzo J, Chirenje ZM, Kabwigu S, Beigi R, Riddler SA, Gafoor Z, Reddy K, Mansoor LE, Nair L, Woeber K, Moodley J, Jeenarain N, Siva S, Naidoo L, Govender V, Palanee-Phillips T.

AIDS. 2019 Aug 12. doi: 10.1097/QAD.0000000000002346. [Epub ahead of print]

PMID:
31408030
2.

Contraceptive method switching among women living in sub-Saharan Africa participating in an HIV-1 prevention trial: a prospective cohort study.

Chappell CA, Harkoo I, Szydlo DW, Bunge KE, Singh D, Nakabiito C, Mhlanga F, Kamira B, Piper JM, Balkus JE, Hillier SL; CAT and MTN-020/ASPIRE Study Team.

Contraception. 2019 Sep;100(3):214-218. doi: 10.1016/j.contraception.2019.06.006. Epub 2019 Jun 19.

PMID:
31226323
3.

Pharmacokinetics of Dapivirine Transfer into Blood Plasma, Breast Milk, and Cervicovaginal Fluid of Lactating Women Using the Dapivirine Vaginal Ring.

Noguchi LM, Hoesley C, Kelly C, Scheckter R, Bunge K, Nel A, Marzinke MA, Hendrix CW, Dezzutti CS, Hillier SL, Bogen DL, Piper JM, Beigi RH.

Antimicrob Agents Chemother. 2019 Feb 26;63(3). pii: e01930-18. doi: 10.1128/AAC.01930-18. Print 2019 Mar.

4.

Vaginal Product Formulation Alters the Innate Antiviral Activity and Glycome of Cervicovaginal Fluids with Implications for Viral Susceptibility.

Koppolu S, Wang L, Mathur A, Nigam JA, Dezzutti CS, Isaacs C, Meyn L, Bunge KE, Moncla BJ, Hillier SL, Rohan LC, Mahal LK.

ACS Infect Dis. 2018 Nov 9;4(11):1613-1622. doi: 10.1021/acsinfecdis.8b00157. Epub 2018 Sep 19.

PMID:
30183260
5.

FAME-04: A Phase 1 trial to assess the safety, acceptability, pharmacokinetics and pharmacodynamics of film and gel formulations of tenofovir.

Bunge KE, Dezzutti CS, Hendrix CW, Marzinke MA, Spiegel HML, Moncla BJ, Schwartz JL, Meyn LA, Richardson-Harman N, Rohan LC, Hillier SL.

J Int AIDS Soc. 2018 Aug;21(8):e25156. doi: 10.1002/jia2.25156.

6.

Heterogeneity of HIV-1 Replication in Ectocervical and Vaginal Tissue Ex Vivo.

Dezzutti CS, Park SY, Marks KM, Lawlor SE, Russo JR, Macio I, Chappell CA, Bunge KE.

AIDS Res Hum Retroviruses. 2018 Feb;34(2):185-192. doi: 10.1089/AID.2017.0107. Epub 2017 Dec 14.

PMID:
28982249
7.

Contraceptive Use and Pregnancy Incidence Among Women Participating in an HIV Prevention Trial.

Akello CA, Bunge KE, Nakabiito C, Mirembe BG, Fowler MG, Mishra A, Marrazzo J, Chirenje ZM, Celum C, Balkus JE.

J Womens Health (Larchmt). 2017 Jun;26(6):670-676. doi: 10.1089/jwh.2016.5958. Epub 2017 Feb 17.

8.

Bacterial species colonizing the vagina of healthy women are not associated with race.

Beamer MA, Austin MN, Avolia HA, Meyn LA, Bunge KE, Hillier SL.

Anaerobe. 2017 Jun;45:40-43. doi: 10.1016/j.anaerobe.2017.02.020. Epub 2017 Feb 24.

9.

Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women.

Baeten JM, Palanee-Phillips T, Brown ER, Schwartz K, Soto-Torres LE, Govender V, Mgodi NM, Matovu Kiweewa F, Nair G, Mhlanga F, Siva S, Bekker LG, Jeenarain N, Gaffoor Z, Martinson F, Makanani B, Pather A, Naidoo L, Husnik M, Richardson BA, Parikh UM, Mellors JW, Marzinke MA, Hendrix CW, van der Straten A, Ramjee G, Chirenje ZM, Nakabiito C, Taha TE, Jones J, Mayo A, Scheckter R, Berthiaume J, Livant E, Jacobson C, Ndase P, White R, Patterson K, Germuga D, Galaska B, Bunge K, Singh D, Szydlo DW, Montgomery ET, Mensch BS, Torjesen K, Grossman CI, Chakhtoura N, Nel A, Rosenberg Z, McGowan I, Hillier S; MTN-020–ASPIRE Study Team.

N Engl J Med. 2016 Dec 1;375(22):2121-2132. Epub 2016 Feb 22.

10.

Corticosteroid-Induced MKP-1 Represses Pro-Inflammatory Cytokine Secretion by Enhancing Activity of Tristetraprolin (TTP) in ASM Cells.

Prabhala P, Bunge K, Ge Q, Ammit AJ.

J Cell Physiol. 2016 Oct;231(10):2153-8. doi: 10.1002/jcp.25327. Epub 2016 Feb 16.

PMID:
26825339
11.

A Phase 1 Trial to Assess the Safety, Acceptability, Pharmacokinetics, and Pharmacodynamics of a Novel Dapivirine Vaginal Film.

Bunge KE, Dezzutti CS, Rohan LC, Hendrix CW, Marzinke MA, Richardson-Harman N, Moncla BJ, Devlin B, Meyn LA, Spiegel HM, Hillier SL.

J Acquir Immune Defic Syndr. 2016 Apr 15;71(5):498-505. doi: 10.1097/QAI.0000000000000897.

12.

Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study.

Noguchi LM, Richardson BA, Baeten JM, Hillier SL, Balkus JE, Chirenje ZM, Bunge K, Ramjee G, Nair G, Palanee-Phillips T, Selepe P, van der Straten A, Parikh UM, Gomez K, Piper JM, Watts DH, Marrazzo JM; VOICE Study Team.

Lancet HIV. 2015 Jul;2(7):e279-87.

13.

Temporal regulation of cytokine mRNA expression by tristetraprolin: dynamic control by p38 MAPK and MKP-1.

Prabhala P, Bunge K, Rahman MM, Ge Q, Clark AR, Ammit AJ.

Am J Physiol Lung Cell Mol Physiol. 2015 May 1;308(9):L973-80. doi: 10.1152/ajplung.00219.2014. Epub 2015 Feb 27.

14.

The effects of reproductive hormones on the physical properties of cervicovaginal fluid.

Chappell CA, Rohan LC, Moncla BJ, Wang L, Meyn LA, Bunge K, Hillier SL.

Am J Obstet Gynecol. 2014 Sep;211(3):226.e1-7. doi: 10.1016/j.ajog.2014.03.041. Epub 2014 Mar 21.

15.

The nucleotide-binding domain and leucine-rich repeat protein-3 inflammasome is not activated in airway smooth muscle upon toll-like receptor-2 ligation.

Hirota JA, Im H, Rahman MM, Rumzhum NN, Manetsch M, Pascoe CD, Bunge K, Alkhouri H, Oliver BG, Ammit AJ.

Am J Respir Cell Mol Biol. 2013 Oct;49(4):517-24. doi: 10.1165/rcmb.2013-0047OC.

PMID:
23614732
16.

HIV-1 infection of female genital tract tissue for use in prevention studies.

Dezzutti CS, Uranker K, Bunge KE, Richardson-Harman N, Macio I, Hillier SL.

J Acquir Immune Defic Syndr. 2013 Aug 15;63(5):548-54. doi: 10.1097/QAI.0b013e318291f331.

17.

The safety, persistence, and acceptability of an antiretroviral microbicide candidate UC781.

Bunge K, Macio I, Meyn L, Noguchi L, Parniak MA, Schwartz JL, Moncla B, Hillier S.

J Acquir Immune Defic Syndr. 2012 Aug 1;60(4):337-43. doi: 10.1097/QAI.0b013e3182575914.

PMID:
22495787
18.

Preformulation and stability in biological fluids of the retrocyclin RC-101, a potential anti-HIV topical microbicide.

Sassi AB, Bunge KE, Hood BL, Conrads TP, Cole AM, Gupta P, Rohan LC.

AIDS Res Ther. 2011 Jul 29;8:27. doi: 10.1186/1742-6405-8-27.

19.

The efficacy of retreatment with the same medication for early treatment failure of bacterial vaginosis.

Bunge KE, Beigi RH, Meyn LA, Hillier SL.

Sex Transm Dis. 2009 Nov;36(11):711-3. doi: 10.1097/OLQ.0b013e3181af6cfd.

PMID:
19652628
20.

Epidemiologic and economic effect of methicillin-resistant Staphylococcus aureus in obstetrics.

Beigi RH, Bunge K, Song Y, Lee BY.

Obstet Gynecol. 2009 May;113(5):983-91. doi: 10.1097/AOG.0b013e3181a116e4.

PMID:
19384112
21.

Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis.

Heldman AW, Cheng L, Jenkins GM, Heller PF, Kim DW, Ware M Jr, Nater C, Hruban RH, Rezai B, Abella BS, Bunge KE, Kinsella JL, Sollott SJ, Lakatta EG, Brinker JA, Hunter WL, Froehlich JP.

Circulation. 2001 May 8;103(18):2289-95.

PMID:
11342479
22.

[Seminars for parents of children born with cleft lip, and jaw and/or palate].

Mühler G, Bunge K.

Stomatol DDR. 1983 Jan;33(1):11-6. German. No abstract available.

PMID:
6573044
23.

[Polarographic determination of substances separated on tl-al-foils (author's transl)].

Oelschläger H, Bunge K, Lim GT, Kraft G.

Arch Pharm (Weinheim). 1974 Oct;307(10):796-801. German. No abstract available.

PMID:
4213652
24.

[Polarographic determination of chlorpromazine as its sulphoxide (author's transl)].

Oelschläger H, Bunge K.

Arch Pharm (Weinheim). 1974 Jun;307(6):410-8. German. No abstract available.

PMID:
4841948
25.

[Poisonings in childhood].

WECHSELBERG K, BUNGE KR.

Monatsschr Kinderheilkd. 1960 May;108:272-7. German. No abstract available.

PMID:
13843353

Supplemental Content

Support Center